TGFB1 and synovial sarcoma: Moreover, matrix (interleukin) IL-17, transforming growth factor β (TGF-β), IL-6, and metalloproteinase (MMP) [11] are also expressed hypothesizing their involvement in the development and the onset of SS through the modulation of target tissue homeostasis and biological activities [13].